These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27407031)

  • 1. Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors.
    Bae YS; Choi S; Park JJ; Joo JH; Cui M; Cho H; Lee WJ; Lee SH
    Bioorg Med Chem; 2016 Sep; 24(18):4144-4151. PubMed ID: 27407031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile synthesis of 5-arylidene thiohydantoin by sequential sulfonylation/desulfination reaction.
    Han J; Dong H; Xu Z; Lei J; Wang M
    Int J Mol Sci; 2013 Jun; 14(6):12484-95. PubMed ID: 23765221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Nitrobenzylidene derivatives or 3-benzoyl-2-thiohydantoin and their pharmacological properties.
    Kleinrok Z; Sermak W; Chodkowska A; Kozicka M
    Ann Univ Mariae Curie Sklodowska Med; 1990; 45():173-80. PubMed ID: 1670022
    [No Abstract]   [Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of Quinoline (Quinolinone) Derivatives as NADPH Oxidase (NOX) Inhibitors.
    Zhang L; Yang X; Yi R; Wu S; Li Q; Hu G; Chen Z
    Chem Biol Drug Des; 2024 Aug; 104(2):e14610. PubMed ID: 39160642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and testing of anticonvulsant properties of 5-benzylidene derivatives of 3-o-, 3-m- I 3-p-chlorophenyl-2-thiohydantoin].
    Rydzik E; Szadowska A; Kiełek MB
    Acta Pol Pharm; 1990; 47(5-6):27-30. PubMed ID: 1669328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of benzylidene derivatives of 3-(m-chlorophenyl)-2-thiohydantoin and studies of their anticonvulsant action].
    Rydzik E; Szadowska A
    Acta Pol Pharm; 1978; 35(5):537-42. PubMed ID: 742379
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synthesis of benzylidene derivatives of 3-O-chlorophenyl-2-thiohydantoin and the study of their anticonvulsive properties].
    Rydzik E; Szadowska A; Kamińska A
    Acta Pol Pharm; 1979; 36(2):167-72. PubMed ID: 532678
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the synthesis and structure-activity relationships of 5-(3'-indolal)-2-thiohydantoin derivatives as aldose reductase enzyme inhibitors.
    Büyükbingöl E; Süzen S; Klopman G
    Farmaco; 1994 Jun; 49(6):443-7. PubMed ID: 8074787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic properties of new 5-benzylidene derivatives of 3-m-nitrophenyl-2-thiohydantoin].
    Kleinrok Z; Kozicka M; Tobiasz-Otrebska K; Sermak W
    Ann Univ Mariae Curie Sklodowska Med; 1985; 40():169-76. PubMed ID: 3917076
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis and anticonvulsant activity of 3-(M-iodophenyl)-5-benzylidine deriviatives of 2-thiohydantoin].
    Dziedzic B; Szadowska A; Kamińska A
    Acta Pol Pharm; 1978; 35(4):423-8. PubMed ID: 707153
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological characterization of the seven human NOX isoforms and their inhibitors.
    Augsburger F; Filippova A; Rasti D; Seredenina T; Lam M; Maghzal G; Mahiout Z; Jansen-Dürr P; Knaus UG; Doroshow J; Stocker R; Krause KH; Jaquet V
    Redox Biol; 2019 Sep; 26():101272. PubMed ID: 31330481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of NADPH oxidase research in cardiovascular pharmacology.
    Rodiño-Janeiro BK; Paradela-Dobarro B; Castiñeiras-Landeira MI; Raposeiras-Roubín S; González-Juanatey JR; Alvarez E
    Vasc Health Risk Manag; 2013; 9():401-28. PubMed ID: 23983473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A search for new anticonvulsant compounds among 3-aryl-5-benzylidene derivatives of 2-thiohydantoin.
    Korohoda MJ; Kleinrok Z; Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(4):329-33. PubMed ID: 981022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.
    Altenhöfer S; Radermacher KA; Kleikers PW; Wingler K; Schmidt HH
    Antioxid Redox Signal; 2015 Aug; 23(5):406-27. PubMed ID: 24383718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones.
    Aboraia AS; Makowski B; Bahja A; Prosser D; Brancale A; Jones G; Simons C
    Eur J Med Chem; 2010 Oct; 45(10):4427-34. PubMed ID: 20655626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of Nox4 inhibitors from edible plants.
    Kofler PA; Pircher H; von Grafenstein S; Diener T; Höll M; Liedl KR; Siems K; Jansen-Dürr P
    Planta Med; 2013 Mar; 79(3-4):244-52. PubMed ID: 23345167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.
    Xu Q; Kulkarni AA; Sajith AM; Hussein D; Brown D; Güner OF; Reddy MD; Watkins EB; Lassègue B; Griendling KK; Bowen JP
    Bioorg Med Chem; 2018 Mar; 26(5):989-998. PubMed ID: 29426628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Search for anticonvulsants among 3-aryl-5-benzylidene and 3-aryl-5-naphtalyl derivatives of 2-thiohydantoin].
    Musial L; Korohoda MJ; Kielek MB; Wojtczak Z
    Acta Pol Pharm; 1976; 33(2):183-90. PubMed ID: 937022
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting NADPH oxidases for the treatment of cancer and inflammation.
    Bonner MY; Arbiser JL
    Cell Mol Life Sci; 2012 Jul; 69(14):2435-42. PubMed ID: 22581366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of N-substituted phenothiazines inhibits NADPH oxidases.
    Seredenina T; Chiriano G; Filippova A; Nayernia Z; Mahiout Z; Fioraso-Cartier L; Plastre O; Scapozza L; Krause KH; Jaquet V
    Free Radic Biol Med; 2015 Sep; 86():239-49. PubMed ID: 26013584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.